Literature DB >> 17412607

Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances.

Helen L Storr1, Li F Chan, Ashley B Grossman, Martin O Savage.   

Abstract

Cushing's syndrome (CS), which is caused by excessive circulating glucocorticoid concentrations, is rare in the paediatric age range but presents a diagnostic and therapeutic challenge. Most paediatric endocrinologists have limited experience of managing children or adolescents with CS and thus benefit from close consultation with colleagues who treat adult patients. A protocol for investigation is required that broadly follows the model for adult patients. Here, the epidemiology and diagnosis of different causes of CS are discussed according to typical age of presentation. Treatment strategies for adrenocorticotrophic hormone (ACTH)-independent and ACTH-dependent CS are described and critically appraised. The management of paediatric CS patients after cure also presents challenges for optimizing growth, bone health, reproduction and body composition from childhood into and during adult life.

Entities:  

Mesh:

Year:  2007        PMID: 17412607     DOI: 10.1016/j.tem.2007.03.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  26 in total

Review 1.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Management of Cushing syndrome in children and adolescents: experience of a single tertiary centre.

Authors:  Maria Güemes; Philip G Murray; Caroline E Brain; Helen A Spoudeas; Catherine J Peters; Peter C Hindmarsh; Mehul T Dattani
Journal:  Eur J Pediatr       Date:  2016-05-12       Impact factor: 3.183

3.  Long-term follow-up on Cushing disease patient after transsphenoidal surgery.

Authors:  Insook Jeong; Moonyeon Oh; Ja Hye Kim; Ja Hyang Cho; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-09-30

Review 4.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

Review 5.  Diagnosis and treatment of pediatric Cushing's disease.

Authors:  Martin O Savage; Helen L Storr; Li F Chan; Ashley B Grossman
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

6.  The growth hormone receptor (GHR) polymorphism in growth-retarded children with Cushing disease: lack of association with growth and measures of the somatotropic axis.

Authors:  L Drori-Herishanu; M Lodish; S Verma; E Bimpaki; M F Keil; A Horvath; C A Stratakis
Journal:  Horm Metab Res       Date:  2009-12-09       Impact factor: 2.936

Review 7.  Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Authors:  George P Chrousos; Tomoshige Kino; Evangelia Charmandari
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

Review 8.  Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.

Authors:  B M K Biller; A B Grossman; P M Stewart; S Melmed; X Bertagna; J Bertherat; M Buchfelder; A Colao; A R Hermus; L J Hofland; A Klibanski; A Lacroix; J R Lindsay; J Newell-Price; L K Nieman; S Petersenn; N Sonino; G K Stalla; B Swearingen; M L Vance; J A H Wass; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  2008-04-15       Impact factor: 5.958

9.  Postoperative testing to predict recurrent Cushing disease in children.

Authors:  Dalia L Batista; Edward H Oldfield; Margaret F Keil; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

Review 10.  Cushing syndrome.

Authors:  Bibek Bista; Nancy Beck
Journal:  Indian J Pediatr       Date:  2013-09-24       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.